Custom service

Neutralizing Antibody Assays

Measure neutralizing capacity of ada against drug mechanism

Turnaround: 8–12 weeksTypical scale: µg – g sample scaleChemistry options: cell-based and non-cell NAb formats; potency-competition design; sensitivity and drug-tolerance validation

Teams come to this service when they need to measure neutralizing capacity of ADA against drug mechanism. We typically start from cell-based and non-cell NAb formats, add potency-competition design where the application demands it, and close the loop with sensitivity and drug-tolerance validation so the final validated NAb assay and sample data behaves consistently across lots.

Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 8–12 weeks timeline holds in practice.

Mechanism-relevant NAb detection

Companion assay to ADA screening

NAb assays without access to the drug mechanism reagent

Samples requiring containment or licensing we do not hold (BSL-3, radioactive)

Analytical reports follow a fixed template: sample condition on receipt, method description with validation status, raw chromatograms and spectra, results with uncertainty, and an interpretation note. Urgent same-week slots are available for release-critical testing.

Service Highlights

  • Cell-based and non-cell NAb formats as the default route, with potency-competition design held as a proven fallback
  • Sensitivity and drug-tolerance validation worked into the design where the application requires it
  • Results are reported with detection limits and method validation status, so you know exactly what the number means
  • Analytical confirmation of every intermediate before the final release
  • Orthogonal methods are used by default — one measurement is an observation, two are data
  • Validated NAb assay and sample data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sample intake & plan

    Samples are logged with chain of custody and the test matrix for Neutralizing Antibody Assays is confirmed.

  2. Method selection

    Analytical methods — cell-based and non-cell NAb formats, potency-competition design — are chosen and their validation status documented.

  3. Measurement

    Testing is executed with system-suitability checks and orthogonal confirmation where required.

  4. Data review

    Chromatograms and spectra are reviewed by a second analyst before any result is issued.

  5. Reporting

    Validated NAb assay and sample data is issued with detection limits and interpretation notes.

  6. Follow-up support

    We discuss anomalies and, where useful, propose the follow-up experiment that resolves them.

Specifications & timeline

Turnaround
8–12 weeks
Typical scale
µg – g sample scale
Chemistry options
cell-based and non-cell NAb formats; potency-competition design; sensitivity and drug-tolerance validation
Deliverable
Validated NAb assay and sample data
QC package
Method report, raw data, validated result with detection limits
Shipping
Blue ice or ambient by material; chain-of-custody on receipt

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.